Ftse Mib
34.184,29
-1,56%
DAX
19.352,03
-0,66%
S&P 500
5.733,64
-0,08%
NASDAQ
18.084,22
-0,20%
Bitcoin
63.869,38
-2,68%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Neorx (MM) (NERX) Neorx (MM) (NERX) Notizie

NERX

Neorx (NERX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NERX
DataOraFonteTitoloSimboloCompagnia
19/06/200614:30PR Newswire (US)Poniard Pharmaceuticals Announces Name Change Effective and Highlights Targeted Objectives for Picoplatin Clinical ProgramNASDAQ:NERX
07/06/200615:00PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Announces Participation in Pacific Growth Equities 2006 Life Sciences Growth ConferNASDAQ:NERXNeorx (MM)
01/06/200615:00PR Newswire (US)Onmark Signs Contracts with Two Additional Pharmaceutical Manufacturers and Enrolls 1,800 MembersNASDAQ:NERX
31/05/200615:00PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Announces Treatment of First Patient With Picoplatin in Phase 1/2 Front-Line ProstaNASDAQ:NERXNeorx (MM)
15/05/200623:15PR Newswire (US)NeoRx Corporation (Poniard Pharmaceuticals) Reports First Quarter Financial ResultsNASDAQ:NERXNeorx (MM)
10/05/200615:00PR Newswire (US)NeoRx Initiates Clinical Trial of Picoplatin in Colorectal Cancer and Announces Name Change to Poniard Pharmaceuticals and ReloNASDAQ:NERXNeorx (MM)
08/05/200615:00PR Newswire (US)NeoRx Announces Participation in Upcoming ConferencesNASDAQ:NERXNeorx (MM)
03/05/200615:00PR Newswire (US)NeoRx to Host Conference Call on May 10 to Provide Corporate and Picoplatin Clinical Development UpdatesNASDAQ:NERXNeorx (MM)
27/04/200615:00PR Newswire (US)NeoRx Closes $65 Million Financing TransactionNASDAQ:NERXNeorx (MM)
25/04/200619:30PR Newswire (US)NeoRx Shareholders Approve Financing TransactionNASDAQ:NERXNeorx (MM)
25/04/200615:00PR Newswire (US)NeoRx Expands Picoplatin Lung Cancer Clinical Trial Into Selected Eastern European CountriesNASDAQ:NERXNeorx (MM)
11/04/200619:13PR Newswire (US)NeoRx Adjourns Special Meeting of ShareholdersNASDAQ:NERXNeorx (MM)
08/03/200622:55PR Newswire (US)NeoRx Corporation's Auditors Expressed Going-Concern QualificationNASDAQ:NERXNeorx (MM)
07/03/200614:00PR Newswire (US)NeoRx Mails Definitive Proxy Statement for Special Shareholder Meeting Set for April 11, 2006NASDAQ:NERXNeorx (MM)
01/03/200622:15PR Newswire (US)NeoRx Reports Fourth Quarter and Full Year Financial ResultsNASDAQ:NERXNeorx (MM)
23/02/200614:00PR Newswire (US)NeoRx Corporation Regains Compliance With Nasdaq Minimum Bid Listing RequirementNASDAQ:NERXNeorx (MM)
02/02/200600:10PR Newswire (US)NeoRx Signs Definitive Agreement for $65 Million Private FinancingNASDAQ:NERXNeorx (MM)
12/01/200602:00PR Newswire (US)NeoRx Receives Notice From Nasdaq Regarding Minimum Bid Price RuleNASDAQ:NERXNeorx (MM)
10/11/200514:01PR Newswire (US)NeoRx Announces Orphan Drug Designation for Picoplatin for Treatment of Small Cell Lung CancerNASDAQ:NERXNeorx (MM)
09/11/200522:05PR Newswire (US)NeoRx Reports Third Quarter 2005 Financial ResultsNASDAQ:NERXNeorx (MM)
01/11/200514:01PR Newswire (US)NeoRx to Present at Rodman & Renshaw Techvest Healthcare ConferenceNASDAQ:NERXNeorx (MM)
11/10/200515:01PR Newswire (US)NeoRx to Present at BIO InvestorForum 2005NASDAQ:NERXNeorx (MM)
27/09/200523:11PR Newswire (US)NeoRx Corporation Regains Compliance with Nasdaq Minimum Bid Listing RequirementNASDAQ:NERXNeorx (MM)
09/08/200523:18PR Newswire (US)NeoRx Reports Second Quarter 2005 Financial ResultsNASDAQ:NERXNeorx (MM)
04/08/200514:30PR Newswire (US)NeoRx Joins The Scripps Research Institute in First Scientific Collaboration at Scripps FloridaNASDAQ:NERXNeorx (MM)
11/07/200516:56PR Newswire (US)NeoRx Announces Treatment of First Patient With Picoplatin in Phase 2 Clinical Trial in Small Cell Lung CancerNASDAQ:NERXNeorx (MM)
27/06/200515:00PR Newswire (US)NeoRx Appoints David A. Karlin, M.D., as Senior Vice President of Clinical Development and Regulatory AffairsNASDAQ:NERXNeorx (MM)
16/06/200515:01PR Newswire (US)NeoRx CEO to Participate in Break-Out Session at Upcoming BIO 2005 ConferenceNASDAQ:NERXNeorx (MM)
10/05/200523:05PR Newswire (US)NeoRx Reports First Quarter Financial ResultsNASDAQ:NERXNeorx (MM)
06/05/200523:15PR Newswire (US)NeoRx Refocusing Resources to Expedite Development of PicoplatinNASDAQ:NERXNeorx (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NERX

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
MONC
Moncler
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
IVG
Iveco Group NV
BIT
LDO
Leonardo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network